Press Releases June 3, 2026 06:00 AM

Yuanbao Inc. to Announce First Quarter 2026 Financial Results on Wednesday, June 10, 2026

Yuanbao Inc. schedules Q1 2026 financial results announcement and earnings call for June 10, 2026.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
YB

Yuanbao Inc., a leading technology-driven online insurance distributor in China, announced it will release its unaudited Q1 2026 financial results on June 10, 2026, before U.S. market open. The company will hold a conference call to discuss results, providing access details via online registration and webcast. Yuanbao leverages technology to deliver customized insurance solutions and collaborates deeply with insurance carriers in China.

Yuanbao Inc. to Announce First Quarter 2026 Financial Results on Wednesday, June 10, 2026
YB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Yuanbao Inc. to release Q1 2026 unaudited financial results on June 10, 2026.
  • Earnings conference call scheduled for June 10 with live and archived webcast available.
  • Company operates as a technology-driven online insurance distributor in China with over ten million consumers served.

BEIJING, June 03, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it will release its first quarter 2026 unaudited financial results on Wednesday, June 10, 2026, before the open of the U.S. markets.

The Company’s management will hold an earnings conference call at 8:00 A.M. U.S. Eastern Time on June 10, 2026 or 8:00 P.M. Beijing Time to discuss the financial results.

Participants should complete online registration using the link provided below at least 15 minutes before the scheduled start time. Upon registration, participants will receive the conference call access information, including dial-in numbers, a personal PIN and an e-mail with detailed instructions to join the conference call.

Participant Online Registration:
https://register-conf.media-server.com/register/BI37c602a9bd0e421dac580195fbc42911

Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at ir.yb-inc.com.

About Yuanbao Inc.

Yuanbao Inc. is a leading technology-driven online insurance distributor in China, committed to protecting health and well-being through innovative technology. Leveraging its proprietary consumer service cycle engine and advanced technologies, Yuanbao delivers customized insurance solutions from its partnered insurance carriers to over ten million insurance consumers throughout the entire insurance lifecycle, ranging from personalized recommendations to post-sales services. Through deep collaboration with insurance carriers and the use of data-driven insights, Yuanbao empowers carriers to tailor flagship products, enhances consumer engagement, and drives scalable and efficient distribution.

For more information, please visit ir.yb-inc.com.

For investor and media inquiries, please contact:

In China:

Yuanbao Inc.
E-mail: ir@yb-inc.com

Piacente Financial Communications
Helen Wu
Tel: +86-10-6508-0677
E-mail: yb@thepiacentegroup.com

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yb@thepiacentegroup.com


Risks

  • Results are unaudited, which may introduce some uncertainty regarding accuracy or adjustments.
  • Dependence on Chinese insurance market regulations and economic conditions impacts company performance.
  • Competitive pressures in online insurance distribution may affect future growth and profitability.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026